Human microRNA-27a* targets Prf1 and GzmB expression to regulate NK-cell cytotoxicity

Area of Science:

• Immunology
• Molecular Biology
• MicroRNA Regulation

Background:

• Natural killer (NK) cells are crucial for immune surveillance and tumor rejection.
• Perforin (Prf1) and granzyme B (GzmB) are key cytotoxic molecules mediating NK cell-mediated killing.
• The precise regulation of Prf1 and GzmB expression during NK cell activation remains incompletely understood.

Purpose of the Study:

• To investigate the role of microRNAs in regulating NK cell cytotoxicity.
• To identify specific microRNAs that control the expression of effector molecules like Prf1 and GzmB.
• To explore the therapeutic potential of modulating microRNA activity in NK cell-based immunotherapies.

Main Methods:

• Analysis of microRNA expression in human NK cells.
• Luciferase reporter assays to confirm direct binding of miR-27a* to Prf1 and GzmB 3' UTRs.
• In vitro cytotoxicity assays and in vivo tumor xenograft models following miR-27a* knockdown in NK cells.

Main Results:

• Human microRNA-27a* (miR-27a*) was identified as a negative regulator of NK cell cytotoxicity.
• miR-27a* directly targets the 3' untranslated regions of Prf1 and GzmB, downregulating their expression.
• Knockdown of miR-27a* in NK cells significantly enhanced their cytotoxic activity against tumor cells in vitro and reduced tumor growth in vivo.

Conclusions:

• NK cell-mediated cytotoxicity is, in part, regulated by microRNA activity.
• miR-27a* acts as a fine-tuner for effector protein homeostasis in NK cells.
• Modulating endogenous miR-27a* levels presents a promising strategy for enhancing NK cell-based cancer immunotherapy.